No Data
Overview of the lifting of restrictions on A-shares | December 30
According to Zhichun Financial APP, on December 30, a total of 37 listed companies had their restricted shares unlocked, with a total market value of approximately 12.254 billion yuan. Today's specific situation of the restricted shares unlocked is as follows: Stock Abbreviation Stock Code Restricted Stock Type Number of Stocks Unlocked Henan Yuneng Holdings 001896 Placement of A-shares for original shareholders 0.205 billion Datang Telecom Technology 600198 Placement of A-shares for original shareholders 0.428 billion China National Software & Service 600536 Stock-based Incentive restricted circulation 0.7513 million Xiamen Tungsten 600549 Stock-based Incentive restricted circulation 3.6369 million Yueyang Forest & Paper 600963 Stock-based Incentive restricted circulation 0.27 million
Jinhe Biotechnology (002688.SZ): Signed a "Global Strategy Cooperation Agreement" with the School of Life Science and Technology at Shanghai Jiao Tong University.
On December 18, Gelonghui reported that Jinhe Biotechnology (002688.SZ) announced that on December 17, 2024, the company signed a "Global Strategy Cooperation Agreement" with the School of Life Science and Technology at Shanghai Jiao Tong University. The two parties intend to establish comprehensive strategic cooperation in the fields of Technology innovation and talent cultivation. The strategic cooperation between the company and the School of Life Science and Technology at Shanghai Jiao Tong University mainly addresses key core technological issues in enterprise production and seeks to find greater development space in the future. Both parties will carry out comprehensive cooperation, deploy a group of strategic, forward-looking, and innovative research projects, focusing on cutting-edge methods of synthetic biology in traditional fermentation research, micro...
Jinhe Biotechnology Includes Sheep, Lambs in Registration of Animal Diarrhea Medication
Jinhe Biotech: Report for the third quarter of 2024
jinhe biotechnology (002688.SZ): net income of 0.114 billion yuan in the first three quarters, a year-on-year increase of 10.38%.
Gelonghui October 27th | Jinhe Biotechnology (002688.SZ) announced that in the first three quarters of 2024, it achieved revenue of 1.657 billion yuan, a year-on-year increase of 5.57%; net income attributable to shareholders of the listed company was 0.114 billion yuan, a year-on-year increase of 10.38%, with basic earnings per share of 0.1461 yuan.
Jinhe Biotechnology (002688.SZ) released its performance for the first three quarters, with a net income of 0.114 billion yuan, a year-on-year increase of 10.38%.
jinhe biotechnology (002688.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Some Jinhe Biotechnology CO., LTD. (SZSE:002688) Shareholders Look For Exit As Shares Take 27% Pounding
